Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical evaluation of dried blood spots for tamoxifen and endoxifen monitoring
NL-OMON40928Not yet recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamoxifen in breast cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Ratio of dried blood spot and serum concentrations of tamoxifen and endoxifen. Planned start Feb 2014; status: not yet recruiting.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON40928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40928.